title: Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication.
abstract: OBJECTIVE
  To assess the safety and efficacy of one, two, or three trabecular microbypass stents in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medication. A total of 119 subjects were followed for 18 months postoperatively.
  
  
  METHODS
  Subjects with medicated intraocular pressure (IOP) 18-30 mmHg and postmedication-washout baseline IOP 22-38 mmHg were randomized to implantation of one, two, or three stents. Ocular hypotensive medication was to be used if postoperative IOP exceeded 18 mmHg.
  
  
  RESULTS
  A total of 38 subjects were implanted with one stent, 41 subjects with two stents, and 40 subjects with three stents. Both month 12 IOP reduction ≥20% without ocular hypotensive medication vs baseline unmedicated IOP and month 12 unmedicated IOP ≤18 mmHg were achieved by 89.2%, 90.2%, and 92.1% of one-, two-, and three-stent eyes, respectively. Furthermore, 64.9%, 85.4%, and 92.1% of the three respective groups achieved unmedicated IOP ≤15 mmHg. Over the 18-month follow-up period, medication was required in seven one-stent subjects, four two-stent subjects, and three three-stent subjects. At 18 months, mean unmedicated IOP was 15.9±0.9 mmHg in one-stent subjects, 14.1±1.0 mmHg in two-stent subjects, and 12.2±1.1 mmHg in three-stent subjects. Month 18 IOP reduction was significantly greater (P<0.001) with implantation of each additional stent, with mean differences in reduction of 1.84 mmHg (95% confidence interval 0.96-2.73) for three-stent vs two-stent groups and 1.73 mmHg (95% confidence interval 0.83-2.64) for two-stent vs one-stent groups. Adverse events through 18 months were limited to cataract progression with best-corrected visual acuity loss and subsequent cataract surgery.
  
  
  CONCLUSIONS
  In this series, implantation of each additional stent resulted in significantly greater IOP reduction with reduced medication use. Titratability of stents as a sole procedure was shown to be effective and safe, with sustained effect through 18 months postoperatively in OAG not controlled with medication.
authors.affiliation: Wills Eye Hospital, Jefferson Medical College, Philadelphia, PA, USA.
authors.forename: L Jay
authors.initials: LJ
authors.lastname: Katz
authors.affiliation: Eye Clinic Wittenbergplatz, Berlin, Germany.
authors.forename: Carl
authors.initials: C
authors.lastname: Erb
authors.affiliation: Department of Ophthalmology, Hospital d'Hebron, Barcelona, Spain.
authors.forename: Guillamet Amadeu
authors.initials: GA
authors.lastname: Carceller
authors.affiliation: University Eye Clinic of the University of Turin, Turin, Italy.
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Fea
authors.affiliation: SV Malayan Opthalmology Centre, Yerevan, Armenia.
authors.forename: Lilit
authors.initials: L
authors.lastname: Voskanyan
authors.affiliation: Glaukos Corporation, Laguna Hills, CA, USA.
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Wells
authors.affiliation: Glaukos Corporation, Laguna Hills, CA, USA.
authors.forename: Jane Ellen
authors.initials: JE
authors.lastname: Giamporcaro
keywords: IOP reduction; MIGS; OAG; iStent; intraocular pressure; multiple stents